156 related articles for article (PubMed ID: 19507252)
21. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
[TBL] [Abstract][Full Text] [Related]
22. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women.
Chan PK; Cheung JL; Cheung TH; Lin CK; Tam AO; Chan DP; Zhou DX; Lo KW; Yim SF; Siu SS
Int J Cancer; 2006 Mar; 118(6):1430-5. PubMed ID: 16206270
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
25. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.
Cuschieri K; Brewster DH; Williams AR; Millan D; Murray G; Nicoll S; Imrie J; Hardie A; Graham C; Cubie HA
Br J Cancer; 2010 Mar; 102(5):930-2. PubMed ID: 20145611
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions.
Chan PK; Li WH; Chan MY; Ma WL; Cheung JL; Cheng AF
J Med Virol; 1999 Oct; 59(2):232-8. PubMed ID: 10459162
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
28. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China.
Wu EQ; Zhang GN; Yu XH; Ren Y; Fan Y; Wu YG; Kong W; Zha X
BMC Cancer; 2008 Jul; 8():202. PubMed ID: 18644159
[TBL] [Abstract][Full Text] [Related]
31. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
33. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
34. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
36. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India.
Pillai RM; Babu JM; Jissa VT; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Reddy KB; Chakka KN; Siddiqui M; Roychoudury S; Abraham P; Peedicayil A; Gnanamony M; Subashini J; Ram TS; Dey B; Singh N; Singh A; Jain SK; Jayshree RS
Int J Gynecol Cancer; 2010 Aug; 20(6):1046-51. PubMed ID: 20683415
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.
Holl K; Nowakowski AM; Powell N; McCluggage WG; Pirog EC; Collas De Souza S; Tjalma WA; Rosenlund M; Fiander A; Castro Sánchez M; Damaskou V; Joura EA; Kirschner B; Koiss R; O'Leary J; Quint W; Reich O; Torné A; Wells M; Rob L; Kolomiets L; Molijn A; Savicheva A; Shipitsyna E; Rosillon D; Jenkins D
Int J Cancer; 2015 Dec; 137(12):2858-68. PubMed ID: 26096203
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancers after human papillomavirus vaccination.
Beller U; Abu-Rustum NR
Obstet Gynecol; 2009 Feb; 113(2 Pt 2):550-552. PubMed ID: 19155953
[TBL] [Abstract][Full Text] [Related]
40. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
